Duarte, CANCT06908928Now EnrollingIRB Ready

Triple Negative Breast Cancer Clinical Trial in Duarte, CA

Access cutting-edge triple negative breast cancer treatment through this clinical trial at a research site in Duarte. Study-provided care at no cost to qualified participants.

Sponsored by Mabwell (Shanghai) Bioscience Co., Ltd.

Quick Self-Assessment

See if you qualify for this Duarte location

Preparing your pre-screening questions…

Expert Care in Duarte

Access triple negative breast cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related triple negative breast cancer treatment provided free

Apply for This Duarte Location

Check if you qualify for this triple negative breast cancer clinical trial in Duarte, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Duarte

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Duarte site if eligible
  4. 4Begin participation

About This Triple Negative Breast Cancer Study in Duarte

The goal of this clinical trial is to investigate if treatment with bulumtatug fuvedotin is effective in triple-negative breast cancer patients who have previously received treatment with an antibody-drug conjugates.

Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd.

Who Can Participate

Inclusion Criteria

Patient has measurable disease by RECIST v1.1
Recurrent or metastatic triple-negative breast cancer patients as per current ASCO/CAP guidelines
Patient has received prior treatment with a taxane and an antibody-drug conjugate with a topoisomerase inhibitor payload.
Patient has received no more than 3 prior lines of cytotoxic therapy in the locally advanced or metastatic setting.
Provision of archival tumor tissue or fresh tumor biopsy.
Capable of giving informed consent
Male or female subjects aged ≥ 18 years.
Subjects must be willing to receive blood transfusions if medically indicated.
Adequate hematologic and organ function
Life expectancy of at least 3 months as assessed by the investigator
Compliance with contraceptive requirement

Exclusion Criteria

Have received any prior treatment with enfortumab vedotin, tisotumab vedotin or other MMAE based or nectin-4 targeted antibody-drug conjugates.
Unstable CNS metastasis requiring treatment in the last 28 days.
Acute infection requiring IV treatment in the last 14 days.
Grade ≥2 peripheral neuropathy.
Pregnant or breastfeeding women.
Life-threatening illness or uncontrolled medical conditions that could compromise the subject's safety or put the study outcomes at risk
Any systemic anticancer therapy in the last 28 days prior to first administration of study drug.
Active HCV, HBV or HIV infection unless well controlled with anti-viral therapy.
Active or chronic corneal disorder, keratitis, corneal ulcerations or Sjogren's syndrome.
Have any ongoing acute inflammatory skin disease or chronic skin disease not well controlled.
Have been diagnosed with another primary malignancy except for adequately treated non-melanoma skin cancer or cervical cancer in situ; definitively treated non-metastatic prostate cancer; or subjects with another primary malignancy who are definitively relapse-free with at least 3 years elapsed since the diagnosis of the other primary malignancy.
Have significant, uncontrolled or active cardiovascular disease
Have active or a history of pneumonitis or interstitial lung disease that requires corticosteroid treatment. Patients with radiation pneumonitis that does not require treatment is allowed.
Have uncontrolled diabetes.
Have received any strong CYP3A4 inhibitors within 14 days prior to the first dose of study drug.
Subjects known to be hypersensitive to bulumtatug fuvedotin or to any components of the formulation.
History of drug abuse including narcotic and psychiatric drugs within 12 months prior to screening.
Have received a live vaccine within 30 days of planned start of study therapy.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Duarte?

Yes, this clinical trial (NCT06908928) has an active research site in Duarte, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Triple Negative Breast Cancer Treatment Options in Duarte, CA

If you're searching for triple negative breast cancer treatment options in Duarte, CA, this clinical trial (NCT06908928) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Duarte research site is actively enrolling participants for this clinical trial. You'll receive care from experienced triple negative breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all triple negative breast cancer clinical trials near you to find additional studies recruiting in your area.

More Breast Cancer Trials in Duarte, CA

See all breast cancer clinical trials recruiting in Duarte — not just this study.

Browse Breast Cancer Trials in Duarte →

Browse More Trials by Condition

Breast Cancer TrialsTriple Negative Breast Cancer TrialsAnkylosing Spondylitis TrialsGeographic Atrophy TrialsAll Conditions →

Ready to Join in Duarte?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Duarte, CA